Receive a specific and actionable roadmap to rapidly advance your ability to demonstrate the value of your med-tech innovation.
The Solid Value Roadmap™ is a short, targeted engagement for early-stage start-ups (typically those who are pre-revenue and pre-seed funding).
Most early-stage firms have a theory of value or perhaps the beginnings of evidence-based value (pilot data, anecdotal value, etc.), but many are facing issues related to their value that they either are unaware of or unable to address. Understanding the components that influence value and identifying gaps in the value evidence can allow founders to focus their efforts on the issues most likely to be raised by key stakeholders, including users, payers, and investors.
Common issues faced by early-stage firms
Many early-stage firms thing they simply lack a clear demonstration of value, but upon a closer look, I have found that these organizations are often struggling with one or more of the following:
- A lack of demand among their current target audience
- Misalignment of who incurs costs and who receives benefits (e.g., nurses asked to implement the innovation on the front lines incur a “cost” of disruption but do not experience monetary savings by the hospital)
- An inability to measure, quantify, monetize, or attribute value to the innovation
- Insufficient value for key stakeholders:
- the opportunity is too small (e.g., rare disease, current care gap is not very costly)
- value capture is too small (e.g., doesn’t “move the needle” enough)
- requires too much investment (e.g., money, time, effort)
- Too much uncertainty or risk that has not been mitigated or addressed
What does the engagement entail?
- An initial list of plausible value messages that align with your overall value prop and direction
- A cursory literature search of available evidence to support these value messages and identify any gaps
- An evaluation of how well the evidence addresses the key components that influence value for relevant perspectives (e.g., clinician, payer, investor, patient, etc.)
- The identification of critical gaps to address
- A suggested strategy for both immediate next steps and longer-term vision, including for evidence generation, value message development, and external-facing material creation
What type of information will I receive?
Each report will incluide specific sections, including suggested value messages:
specific needs or gaps:
This engagement is designed to meet the specific needs (and budget) of early-stage start-ups. Reach out for more information.
“Craig was able to help us craft clear logic that allows us to illustrate the true value that had not previously been fully identified. Craig was very flexible as our needs evolved, and we ultimately procduced a clear value proposition for our new technology.”
“Craig was responsive to last-minute requests and was able to accommodate our busy schedules. Upon project completion, Craig provided us with guidance for future projects, including opportunities to show further value created by our programs.”
“I had a great experience working with Craig. He is one of the smartest people that I met in the healthcare community and his insights have been very helpful. Craig also has a no nonsense approach to our collaboration and I always learn something new when I have a conversation with Craig. Also, Craig is very generous with opening up his rolodex. We met many great people through Craig and we are very grateful for that. We will reach out to Craig soon for more collaborations.“
Select Client List:
American Medical Association (AMA) • Stratis Health • Oklahoma Foundation for Medical Quality • Optum • University of Minnesota • Indiana University • American Society of Clinical Oncologists (ASCO) • ICSI • Kidney Care Quality Alliance (KCQA) • Medtronic • NYU • Boston Scientific • Harvard Medical School • MPRO • Telligen • E4 Enterprise • Lee Branding • MetaStar